These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31554391)

  • 1. The Role of Intestinal Fungi and Its Metabolites in Chronic Liver Diseases.
    You N; Zhuo L; Zhou J; Song Y; Shi J
    Gut Liver; 2020 May; 14(3):291-296. PubMed ID: 31554391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics and research progress on the role of intestinal fungi in chronic liver disease].
    Zhang LL; Deng WH; Wang WX
    Zhonghua Gan Zang Bing Za Zhi; 2022 Nov; 30(11):1285-1288. PubMed ID: 36891713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of gut microbiota in chronic liver diseases, and treatment possibilities].
    Hagymási K; Bacsárdi A; Egresi A; Berta E; Tulassay Z; Lengyel G
    Orv Hetil; 2018 Sep; 159(36):1465-1474. PubMed ID: 30175608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indoles: metabolites produced by intestinal bacteria capable of controlling liver disease manifestation.
    Hendrikx T; Schnabl B
    J Intern Med; 2019 Jul; 286(1):32-40. PubMed ID: 30873652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal microbiota in liver disease.
    Haque TR; Barritt AS
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):133-42. PubMed ID: 27048904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fungi-Bacteria Correlation in Alcoholic Hepatitis Patients.
    Gao B; Zhang X; Schnabl B
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33672887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of gut microbiota in liver disease.
    Albhaisi SAM; Bajaj JS; Sanyal AJ
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G84-G98. PubMed ID: 31657225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of intestinal microbiota in the formation of non-alcoholic fatty liver disease.
    Akhmedov VA; Gaus OV
    Ter Arkh; 2019 Mar; 91(2):143-148. PubMed ID: 31094185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gut-liver axis: How intestinal bacteria affect the liver].
    Konturek PC; Harsch IA; Konturek K; Schink M; Zopf Y
    MMW Fortschr Med; 2018 Nov; 160(Suppl 5):11-15. PubMed ID: 30367438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial proteins: intestinal guards to protect against liver disease.
    Hendrikx T; Schnabl B
    J Gastroenterol; 2019 Mar; 54(3):209-217. PubMed ID: 30392013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Intestinal Microbiome in Nonalcoholic Fatty Liver Disease.
    Puri P; Sanyal AJ
    Clin Liver Dis; 2018 Feb; 22(1):121-132. PubMed ID: 29128052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of intestinal bacteria with fatty liver diseases and cirrhosis.
    Guohong-Liu ; Qingxi-Zhao ; Hongyun-Wei
    Ann Hepatol; 2019; 18(6):796-803. PubMed ID: 31558417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal virome: An important research direction for alcoholic and nonalcoholic liver diseases.
    Li Y; Liu WC; Chang B
    World J Gastroenterol; 2022 Jul; 28(26):3279-3281. PubMed ID: 36051333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the gut microbiota in type 2 diabetes and related diseases.
    Yang G; Wei J; Liu P; Zhang Q; Tian Y; Hou G; Meng L; Xin Y; Jiang X
    Metabolism; 2021 Apr; 117():154712. PubMed ID: 33497712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
    Woodhouse CA; Patel VC; Singanayagam A; Shawcross DL
    Aliment Pharmacol Ther; 2018 Jan; 47(2):192-202. PubMed ID: 29083037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gut mycobiome: a novel player in chronic liver diseases.
    Jiang L; Stärkel P; Fan JG; Fouts DE; Bacher P; Schnabl B
    J Gastroenterol; 2021 Jan; 56(1):1-11. PubMed ID: 33151407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Probiotics on the Production of Short-Chain Fatty Acids by Human Intestinal Microbiome.
    Markowiak-Kopeć P; Śliżewska K
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32316181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin A and liver diseases.
    Inamine T; Schnabl B
    J Gastroenterol; 2018 Jun; 53(6):691-700. PubMed ID: 29075899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal Barrier Function-Non-alcoholic Fatty Liver Disease Interactions and Possible Role of Gut Microbiota.
    Cui Y; Wang Q; Chang R; Zhou X; Xu C
    J Agric Food Chem; 2019 Mar; 67(10):2754-2762. PubMed ID: 30798598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal Microbiota Transplantation for Chronic Liver Diseases: Current Understanding and Future Direction.
    Lechner S; Yee M; Limketkai BN; Pham EA
    Dig Dis Sci; 2020 Mar; 65(3):897-905. PubMed ID: 32020359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.